What is .decimal?
.decimal operates as a specialized manufacturer of patient-specific radiation therapy devices, providing essential hardware for Proton, Electron, and Photon treatment modalities. The company has established a robust market presence by facilitating the on-demand design and delivery of custom medical devices, currently supporting over 150,000 cancer patients across 949 clinics in the United States. With a track record of producing over 530,639 devices, the firm serves as a vital link in the clinical supply chain, offering contract manufacturing services and comprehensive material safety data management. Their business model centers on precision engineering and rapid turnaround, which are critical requirements for modern, high-acuity cancer care environments.
How much funding has .decimal raised?
.decimal has raised a total of $975K across 2 funding rounds:
Debt
$350K
Debt
$625K
Debt (2020): $350K with participation from PPP
Debt (2021): $625K led by PPP
Key Investors in .decimal
PPP
Public-Private Partnership
What's next for .decimal?
With the infusion of this recent capital, .decimal is expected to scale its manufacturing capacity to meet the rising demand for personalized oncology solutions. The company's strategic roadmap likely involves enhancing its digital design platforms and optimizing its logistics network to further reduce lead times for clinics. As the healthcare industry shifts toward more individualized treatment protocols, .decimal is positioned to leverage its existing infrastructure to capture additional market share. Future growth will likely focus on deepening integration with clinical workflows and potentially expanding its service offerings to include advanced material innovations, ensuring the company remains at the forefront of radiation therapy technology.
See full .decimal company page
